D-1332-2022 Class II Terminated

Recalled by SterRx, LLC — Plattsburgh, NY

FDA drug recall D-1332-2022 was initiated by SterRx, LLC on Jul 25, 2022 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Jun 22, 2023). Affected quantity: 360 bags.

Recall Details

Product Type
Drugs
Report Date
Aug 17, 2022
Initiation Date
Jul 25, 2022
Termination Date
Jun 22, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
360 bags

Product Description

fentaNYL Citrate in 0.9% Sodium Chloride, 2.5 mg per 250 mL, (10 mcg per mL) IV bags, Rx Only, SterRx, 141 Idaho Avenue, Plattsburgh, NY 12903, NDC 70324-327-02.

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: CHL, Exp. Date Dec 29, 2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1332-2022
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1332-2022. Report a data issue: hello@regdatalab.com.